These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1856 related articles for article (PubMed ID: 34111579)

  • 1. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
    Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
    Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
    Peghin M; De Martino M; Palese A; Gerussi V; Bontempo G; Graziano E; Visintini E; D'Elia D; Dellai F; Marrella F; Fabris M; Curcio F; Sartor A; Isola M; Tascini C
    Clin Microbiol Infect; 2022 Aug; 28(8):1140-1148. PubMed ID: 35339673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.
    Collins E; Galipeau Y; Arnold C; Bhéreur A; Booth R; Buchan AC; Cooper C; Crawley AM; McCluskie PS; McGuinty M; Pelchat M; Rocheleau L; Saginur R; Gravel C; Hawken S; Langlois MA; Little J
    Front Public Health; 2024; 12():1276391. PubMed ID: 38784593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
    Peghin M; Bouza E; Fabris M; De Martino M; Palese A; Bontempo G; Graziano E; Gerussi V; Bressan V; Sartor A; Isola M; Tascini C; Curcio F
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2597-2604. PubMed ID: 34378086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population.
    Bichara CDA; da Silva Graça Amoras E; Vaz GL; da Silva Torres MK; Queiroz MAF; do Amaral IPC; Vallinoto IMVC; Bichara CNC; Vallinoto ACR
    BMC Infect Dis; 2021 May; 21(1):443. PubMed ID: 33992073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
    Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
    J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.
    Peghin M; De Martino M; Fabris M; Palese A; Visintini E; Graziano E; Gerussi V; Bontempo G; D'Aurizio F; Biasotto A; Sartor A; Pipan C; Marzinotto S; Curcio F; Bouza E; Isola M; Tascini C
    J Clin Microbiol; 2021 Oct; 59(11):e0113821. PubMed ID: 34379530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
    Sakhi H; Dahmane D; Attias P; Kofman T; Bouvier M; Lapidus N; Fourati S; El Karoui K;
    J Am Soc Nephrol; 2021 May; 32(5):1033-1036. PubMed ID: 33637518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
    Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
    J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
    Horton DB; Barrett ES; Roy J; Gennaro ML; Andrews T; Greenberg P; Bruiners N; Datta P; Ukey R; Velusamy SK; Fine D; Honnen WJ; Yin YS; Pinter A; Brooks A; Tischfield J; Hussain S; Jagpal S; Swaminathan S; Parmar V; Reilly N; Gaur S; Panettieri RA; Carson JL; Blaser MJ
    J Infect Dis; 2021 Oct; 224(8):1345-1356. PubMed ID: 34387310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.
    García-Abellán J; Padilla S; Fernández-González M; García JA; Agulló V; Andreo M; Ruiz S; Galiana A; Gutiérrez F; Masiá M
    J Clin Immunol; 2021 Oct; 41(7):1490-1501. PubMed ID: 34273064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Tancevski I; Weiss G; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 May; 59(6):1143-1154. PubMed ID: 33554557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female gender is associated with long COVID syndrome: a prospective cohort study.
    Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD
    Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study.
    Theuri M; Ndombi EM; Thamaini P; Ogutu JO; Onsongo L; Madete JK; Ofula V; Gitau S; Mwangi G; Okemo P
    PeerJ; 2024; 12():e17723. PubMed ID: 39056056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of IgG antibodies kinetics after severe and critical COVID-19.
    De Greef J; Scohy A; Zech F; Aboubakar F; Pilette C; Gerard L; Pothen L; Yildiz H; Belkhir L; Yombi JC
    J Med Virol; 2021 Sep; 93(9):5416-5424. PubMed ID: 33945634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 93.